Wesley S. Lobo - 16 Feb 2022 Form 4 Insider Report for NEPHROS INC (NEPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Feb 2022, 16:03:01 UTC
Prior SEC filing
03 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ted Peilen as attorney-in-fact for Wesley S. Lobo pursuant to a power of attorney filed previously.

Key filing fact

Wesley S. Lobo filed Form 4 for NEPHROS INC (NEPH) on 18 Feb 2022.

Key facts

  • This page summarizes Wesley S. Lobo's Form 4 filing for NEPHROS INC (NEPH).
  • 1 reported transaction and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2022, 16:03.

Change

  • Previous filing in this sequence was filed on 03 Sep 2021.
  • Current net transaction value: -$30,667.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH transaction

Common Stock

Tax liability

Transaction value
$30,667
Shares
-6,389
Change %
-15%
Price
$4.80
Shares after
35,168
Date
16 Feb 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEPH holding Derivative

Stock Optoin (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
114,178
Date
16 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
114,178
Exercise price
$8.66
Footnotes
F3
NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
57,368
Date
16 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
57,368
Exercise price
$8.47
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant.

Footnote F2

Includes 15,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/23, 2/16/24 and 2/16/25.

Footnote F3

Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.

Footnote F4

Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .